
PhD Clinical Microbiologist, Infectious Diseases researcher and IBM-certified Data Analyst with 10+ years translating signal into strategy — from AMR fieldwork to data classification, data usability and founding Edutrique and Edoway.
I architect outcomes at the seam of science, strategy and service. Over the last decade I've moved deliberately between worlds — diagnosing HIV/AIDS samples at APIN Public Health, running regional logistics for DHL, lecturing microbiology at Fidei Polytechnic, and founding two ventures.
My research focuses on antimicrobial resistance, antifungal natural products and enteric pathogens — grounded in fieldwork across Nigeria. Alongside the bench, I work as a data analyst — sourcing, classifying and shaping datasets so that organisations can actually use them to decide, fund and act.
The thread is constant: whether I'm classifying a pathogen, a dataset or a market signal, I'm fascinated by how good classification, usability and analytics at every level produce healthier outcomes — biological, organisational and economic.
A toolkit forged across science, public health and venture building over 10+ years.
Leading a virtual guide platform for financial success and lifestyle enhancement. Strategy, partnerships and user growth.
A global research and training platform improving access to educational resources for diverse learners.
Coordinating postgraduate programmes, institutional linkages and academic partnerships.
Oversight of logistics and outsourcing operations as the executive officer of the organisation.
Diagnostic operations across HIV/AIDS and maternal healthcare patient pathways.
Coordinating microbiology research and lectures, leading departmental strategy and curriculum.
Directed regional logistics operations and competitor strategy analysis.
Selected peer-reviewed work on antimicrobial resistance, antifungal natural products and enteric pathogens.
Evaluation against selected pathogenic fungi.
Public-health hazards associated with waste streams in Gboko, Nigeria.
In-vitro inhibition in HIV patients in Jos, Nigeria.
Antibacterial efficacy versus generic antibacterial agents.
Research collaborations, advisory roles, speaking engagements, or venture conversations — the inbox is open.